Trial intelligence / Profile preview

NAC for Cocaine Dependence

NCT00218491Phase 2Completed

Sponsor
Medical University of South Carolina
Start
Nov 2005
Primary completion
May 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of acetylcysteine in cocaine dependence (3 arms), sponsored by Medical University of South Carolina. Primary endpoint: Number of Participants That Achieved Study Compliance at 8 weeks. Started Nov 2005; status: completed.

02

Drugs

acetylcysteine
03

Conditions

cocaine dependence

Beyond the preview

Go deeper on NCT00218491.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00218491.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call